UH performed the first case using the system Nov. 10. The Stealth Autoguide cranial robotic platform is designed for surgeries on adult and pediatric patients with neurological conditions. Using the platform, a surgeon can place an electrode or catheter in the brain or perform a biopsy with more precise movements while receiving continuous real-time visualization and feedback through the computer.
UH brain tumor and neuro-oncology center director Andrew Sloan, MD, said Medtronic chose the health system to begin using the tech because of its experience with laser interstitial thermal therapy, which is a technique used to treat primary and metastatic brain tumors that are hard to reach with conventional surgery.
More articles on health IT:
Former Cleveland Clinic CIO on retail competition: Hospitals must make digital changes or ‘become relic of the past’
States ranked by tech, science capabilities
COVID-19 vaccines must be accompanied by public education campaigns, experts say
